首页> 外国专利> ADULT T-CELL LEUKEMIA ONSET RISK DETERMINATION METHOD

ADULT T-CELL LEUKEMIA ONSET RISK DETERMINATION METHOD

机译:成人T细胞白血病起病风险确定方法

摘要

PROBLEM TO BE SOLVED: To provide an improved method and a kit for determining an adult T-cell leukemia (ATL) onset risk in a human T-lymphotropic virus 1 type carrier (HTLV-1 carrier), convalescence after a marrow transplant in an ATL patient, and the acute transformation of ATL in a smoldering type or chronic type ATL patient, and a treatment policy after the acute transformation in the smoldering or chronic ATL patent.;SOLUTION: CD30 in a sample is measured. According to the measurement value, an ATL onset risk in an HTLV-1 carrier, convalescence after a marrow transplant in the ATL patient, and the acute transformation of ATL in the smoldering type or chronic type ATL patient can be determined. Also, CD30, an interleukin-2 acceptor or lactate dehydrogenase activity in a sample is measured, and a treatment policy when the smoldering type or chronic type ATL patient is subjected to acute transformation can be determined according to the measurement value.;COPYRIGHT: (C)2009,JPO&INPIT
机译:解决的问题:提供一种改进的方法和试剂盒,用于确定人T淋巴细胞病毒1型载体(HTLV-1载体)中成年T细胞白血病(ATL)的发病风险,骨髓移植后的恢复期。 ATL患者,以及阴燃或慢性ATL患者中ATL的急性转化,以及阴燃或慢性ATL专利中急性转化后的治疗策略。解决方案:测量样品中的CD30。根据测量值,可以确定HTLV-1携带者的ATL发病风险,ATL患者骨髓移植后的恢复期以及阴燃型或慢性型ATL患者的ATL急性转化。同样,测量样品中CD30,白介素2受体或乳酸脱氢酶的活性,并根据测量值确定阴燃型或慢性型ATL患者进行急性转化时的治疗策略。 C)2009,日本特许厅

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号